GLP-1 Analogs Represent a Novel Treatment Strategy for Diabetic Encephalopathy

被引：0
|
作者：
Okouchi, Masahiro
Okayama, Naotsuka
Shigeki, Goji
Iwama, Tadashi
Katsuno, Tetsuya
Asada, Kaoru
Hattori, Kohei
Goto, Akitomo
Kamiya, Yasutaka
Ohno, Tsuneo
Joh, Takashi
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
569-P
引用
收藏
页码：A145 / A145
页数：1
相关论文
共 50 条
  • [11] Novel DPP-IV-resistant analogs of GLP-1: The N-terminal extension of GLP-1 by a single amino acid
    Oh, Ji-Yeon
    Lee, ChangWoo
    Jang, Sei-Heon
    Yoo, Seung-Bum
    Chung, Hye-Shin
    Bulletin of the Korean Chemical Society, 2009, 30 (10) : 2471 - 2474
  • [12] Design and evaluation of novel thrombin-based GLP-1 analogs with peptidic albumin binding domain for the controlled release of GLP-1
    Niu, Xianli
    Nong, Shirong
    Zhang, Xiaomin
    Li, Xiangyang
    Wang, Cheng
    Li, Wei
    Zhou, Tianhong
    RSC ADVANCES, 2020, 10 (08) : 4725 - 4732
  • [13] Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential
    Torekov, S. S.
    Madsbad, S.
    Holst, J. J.
    OBESITY REVIEWS, 2011, 12 (08) : 593 - 601
  • [14] Novel long-acting GLP-1 analogs with superior in vivo bioavailability
    Sakamuri, Sukumar
    Huang, Jie
    Fu, Yanwen
    Oates, Bryan
    Hatcher, Ellen
    Betancourt, Oscar
    Del Rosario, Joselyn
    Callans, Sherri
    Murphy, Robert
    Lappe, Rodney
    Woodnutt, Gary
    Bradshaw, Curt
    Levin, Nancy
    DIABETES, 2007, 56 : A151 - A151
  • [15] Novel Approach to Sarcopenia in Diabetic Patients Treated with GLP-1 Receptor Agonists (GLP-1RA)
    Ikejima, Shin
    Kondo, Seiya
    Sakai, Takenori
    Taniai, Hisanori
    Takahashi, Tomomi
    Umezu, Junko
    Iseka, Mami
    Inoue, Maya
    Nishihara, Harumi
    Murata, Kazuya
    Hirai, Aizan
    DIABETES, 2018, 67
  • [16] Understanding GLP-1 Analogs and Enhancing Patient Success
    Kruger, Davida F.
    Bode, Bruce
    Spollett, Geralyn R.
    DIABETES EDUCATOR, 2010, 36 : 44S - 72S
  • [17] Biological activities of GLP-1 analogs in vitro and in vivo
    Xiao, Q
    Giguere, J
    Jeng, W
    Pierre, SS
    Brubaker, PL
    Wheeler, MB
    DIABETES, 2000, 49 : A227 - A227
  • [18] High dosage GLP-1 analogs are now available
    Pampel S.L.
    MMW - Fortschritte der Medizin, 2016, 158 (7) : 72 - 72
  • [19] Novel GLP-1 analog supaglutide improves glucose homeostasis in diabetic monkeys
    Cui, Qiaoli
    Liao, Yijing
    Jiang, Yaojing
    Huang, Xiaohang
    Tao, Weihong
    Zhou, Quanquan
    Shao, Anna
    Zhao, Ying
    Li, Jia
    Ma, Anran
    Wang, Zhihong
    Zhang, Li
    Yang, Zunyuan
    Liang, Yinan
    Wu, Minglin
    Yang, Zhenyan
    Zeng, Wen
    Wang, Qinghua
    JOURNAL OF ENDOCRINOLOGY, 2021, 248 (02) : 145 - 154
  • [20] Design and synthesis of novel GLP-1 analogs that have significantly improved in vivo activities
    Dong, Jesse Z.
    Shen, Yeelana
    Zhang, Jundong
    Taylor, John E.
    Woon, Chee-Wai
    Morgan, Barry
    Skinner, Steve
    Cawthorne, Michael
    Culler, Michael
    Moreau, Jacques-Pierre
    PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS, 2004, : 625 - 627
12345